About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Advertisement

Medindia » Health Press Releases A-Z

Demand Better For Patients, For Survival During Pancreatic Cancer Awareness Month This November

Advertisement

Pancreatic Cancer Action Network Spotlights Urgent Need for Early Detection to Fight the World's Toughest Cancer

November is Pancreatic Cancer Awareness Month. Please join us as we Demand Better. For Patients. For Survival. Please take action today for everyone affected by pancreatic cancer. With your help, we will double survival by 2020! www.pancan.org/demandbetter

Advertisement

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve outcomes today and to double survival by 2020. (PRNewsfoto/Pancreatic Cancer Action Network)

Sponsored Post and Backlink Submission

Latest Press Release on Cancer News

Cancer Patients Can't Afford Pet Food and Vet Care, CancerCare Survey Finds

Some Cancer Patients Would Rather Stop Treatment Than Give Up Their Pets NEW YORK , April 18, 2024 /PRNewswire/ -- The companionship and support of a pet can be a lifeline for...

24th World Congress on Cancer and Diagnostics

We are delighted to extend a warm greeting to you on behalf of the organizing committee for the 24th World Congress on Cancer and Diagnostics which will be held in the vivacious city of Vanc...

Derm-biome Pharmaceuticals' Topical Therapy Shows Positive Results in Preclinical Skin Cancer Trial: Drug Prevents the Development of Precancerous Skin Conditions and Treats Existing Skin Cancers With No Observable Side Effects

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (A...

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting

TEL AVIV, Israel , April 17, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in onco...

Biotech Innovations Paving the Way in Breast Cancer Fight

FN Media Group Presents USA News Group News Commentary VANCOUVER, BC , April 11, 2024 /PRNewswire/ -- USA News Group – The American Cancer Society is projecting 20...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close